Cancer Cells Acquire Mitotic Drug Resistance Properties Through Beta I-Tubulin Mutations and Alterations in the Expression of Beta-Tubulin Isotypes

Chun Hei Antonio Cheung, Su-Ying Wu, Tian-Ren Lee et al. · 2010

Read Cancer Cells Acquire Mitotic Drug Resistance Properties Through Beta I-Tubulin Mutations and Alterations in the Expression of Beta-Tubulin Isotypes by Chun Hei Antonio Cheung, Su-Ying Wu, Tian-Ren Lee et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012564.txt.

Description

Chun Hei Cheung, Su-Ying Wu, Tian-Ren Lee and colleagues studied how cancer cells learn to dodge anti-mitotic drugs, in a 2010 PLOS ONE paper. Drugs like vincristine and vinblastine jam the microtubule ropes that pull chromosomes apart, and they cure many cancers — until resistance emerges. Microtubules are built from tubulin, including the beta I form the team examined.

Mutations in beta I tubulin and shifts in which tubulin types the cell used gave cells drug resistance during division. Knowing the exact escape changes lets chemists design next-generation blockers that grip differently. It also suggests tests to predict which patients' tumors already carry the escape.

Catalog record

CREATORChun Hei Antonio Cheung, Su-Ying Wu, Tian-Ren Lee et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012564

Browse the full library · About the Tower of Babel